Literature DB >> 17013752

Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin's disease.

M T Ferrò, T Riccardi, A Montanelli, P Bernasconi, R Mantegazza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17013752     DOI： 10.1007/s00415-006-0171-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

Review 1.  Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues.

Authors:  E Maggio; A van den Berg; A Diepstra; J Kluiver; L Visser; S Poppema
Journal:  Ann Oncol       Date:  2002       Impact factor: 32.976

2.  Hodgkin's disease of the thymus (granulomatous thymoma) and myasthenia gravis: a unique association.

Authors:  J A Null; V A Livolsi; W W Glenn
Journal:  Am J Clin Pathol       Date:  1977-06       Impact factor: 2.493

3.  Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy.

Authors:  L E Abrey
Journal:  Neurology       Date:  1995-05       Impact factor: 9.910

4.  "Extended" thymectomy, without sternotomy, performed by cervicotomy and thoracoscopic technique in the treatment of myasthenia gravis.

Authors:  L Novellino; M Longoni; L Spinelli; M Andretta; M Cozzi; G Faillace; M Vitellaro; D De Benedetti; G Pezzuoli
Journal:  Int Surg       Date:  1994 Oct-Dec

Review 5.  From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. The Second Conference on Biological and Clinical Aspects of Thymic Epithelial Tumors and related recent developments.

Authors:  A Marx; H K Müller-Hermelink
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

6.  Myasthenia gravis and thymic Hodgkin's disease associated in one patient with familial lymphoproliferative disorders.

Authors:  L Padua; M T Palmisani; G Di Trapani; A Evoli; L M Larrocca; P Tonali
Journal:  Clin Neuropathol       Date:  1994 Sep-Oct       Impact factor: 1.368

Review 7.  [Myasthenic syndrome disclosing Hodgkin disease].

Authors:  R Quilichini; P Fuentes; G Metge; A Lafeuillade; J Albatro
Journal:  Rev Neurol (Paris)       Date:  1994       Impact factor: 2.607

Review 8.  Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.

Authors:  Luis Bataller; Josep Dalmau
Journal:  Semin Neurol       Date:  2003-06       Impact factor: 3.420

9.  Seronegative myasthenia gravis and familial Hodgkin's disease.

Authors:  C Tranchant; E Racamier; J M Warter
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710
  9 in total
  2 in total

Review 1.  Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.

Authors:  Alexis L Franks; Jill E Slansky
Journal:  Anticancer Res       Date:  2012-04       Impact factor: 2.480

2.  Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the Literature.

Authors:  Marcus Vetter; Alexandar Tzankov; Andreas Engert; Matthias Mehling; Richard Herrmann; Christoph Rochlitz
Journal:  Case Rep Oncol       Date:  2011-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.